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Comparison of Estradiol-Trenbolone Acetate Implant
Programs for Yearling Steers of Two Genotypes
Robbl H. Pritchard
Department of Animal and Range Sciences
CATTLE 98-1
Summary
Yearling steers (n = 400) were used to evaluate relative payout periods for implants when feeding high
grain content diets. Implant treatments included (1) control (nonimplanted), (2) Synovex Plus, (3) revalor-s,
and (4) Ralgro-revalor-s. The Synovex Plus (2), revalor-s (3) and Ralgro (4) were administered on day 1.
The reimplant with revalor-s (4) was admnistered after 56 d on feed. Steers were managed in two groups.
Initial BW and days fed were 782 lb, 131 d (Group I), and 661 lb, 145 d (Group II). Implants increased
production rates and efficiencies, increased carcass size and reduced marbling when compared to
nonimplanted controls. Production rates and efficiencies and carcass sizes were similar among steers that
received implants. Marbling scores and percentage choice carcasses were affected by implants. In general,
the delayed use of an estradiol-trenbolone acetate implant improved marbling over d 1 implanting even
though there were 56 fewer days on feed after implanting. The energy density of live weight gain was
calculated over the course of the feeding period based upon interim period BW and DMI determinations.
Higher energy content of gain early in the feeding period for treatments 1 and 4 were related to marbling,
while the energy content of gain late in feeding period was not. These data showed no differences in the
relative effective duration of Synovex Plus and revalor-s implants. The influence of implants on carcass
quality grades was affected by factors other than elapsed time from implanting to harvest.
Introduction
Optimizing implant strategies requires striking a balance between implant payout, production costs, and
carcass specifications. The influence of implants on cost of gain erodes over time. This encourages
shortening the expected payout of the implant. However, it is generally considered that carcass marbling is
increased as the elapsed time from implanting to slaughter is increased. The label associated with implant
clearances generally does not stipulate how prolonged exposure to the implant relates to these conflicting
variables.
Presently there are two estradiol-trenbolone acetate implant formulations available for use in steers being
fed for slaughter. One product provides 24 mg estradiol and 120 mg trenbolone acetate. A second
available product provides the equivalent of 20 mg estradiol as estradiol benzoate and 200 mg trenbolone
acetate. These are potent tools for improving production rates in steers. The concentration and proportion
of active ingredients in these implants differ as does the carrier matrix. This experiment was designed to
compare the relative payout of these products. The information is intended to help producers define the
time exposure appropriate for their production constraints.
To evaluate effective payout, it is advantageous to have a nonimplanted control to use as a reference point
during growth. It would also be advantageous to have a positive control that provides high levels of implant
payout during the same time frame associated with the expected depletion of the test implant(s). This
could be accomplished by administering implants in a staggered time schedule in the positive control
treatment. Coincidentally, this would also allow consideration of a re-implant program.
In the experiment described here we wished to evaluate the relative effective payout for revalor-s (20 mg
estradiol/120 mg trenbolone acetate) and Synovex Plus (28 mg estradiol benzoate/200 mg trenbolone
acetate). Nonimplanted steers were used as the negative control. The positive control involved delaying
revalor-s implanting for 56 d to provide a staggered payout during the later stages of the feeding period. In
the positive control Ralgro (36 mg zeranol) was used to provide growth promoting activity during the initial
56 d on feed.
Approach
The implant strategies used included (1) Control (nonimplanted); (2) Synovex Plus; (3) revalor-s; and (4)
Ralgro-revalor-s. The Synovex Plus (2), revalor-s (3), and Ralgro (4) were administered on day 1. The
re-implant with revalor-s (4) was administered after 56 d on feed.
Forty pens of 10 steers were assigned to the experiment. Steers were purchased as two major groups.
Group I consisted primarily of black hided steers and Group II was predominately continental crosses. Each
group provided enough steers to fill 20 pens (5 pens per implant treatment per group). The groups were fed
and managed as distinctive lots of cattle to accommodate differences in implant response and marketing
needs that could occur between differing biological types. The nutrition, processing and implant
management were common across groups. Days on feed were 131 for Group I and 145 for Group II.
The 200 steers used in Group I were selected from a group of 223 steers. The Group II steers (n = 200)
were drawn from a pool of 234 steers. At arrival cattle were observed for thriftiness, structural soundness
and type characteristics. Any unacceptable subjects were deleted. Within a source group, cattle were
ranked by arrival BW and outliers were deleted. Once the pool was reduced to 200 subjects, treatment was
assigned (1 to 4) using a random sequence of treatment codes. Data were resorted by treatment and BW
and assigned a random sequence of replicate codes. The treatment-replicate combinations were then
assigned pen numbers such that treatment was randomly distributed throughout the 20 pens allocated to
the group. This allotment system distributed BW ranges similarly in all pens. Starting dates were May 1,
1996, for Group I and May 23, 1996, for Group II.
Incoming cattle were eartagged and then vaccinated for IBR, BVD, PI3, BRSV,,H. somnus and 7 clostridial
sp using Ultrabac 7 and Resvac 4/somubac ^ . Parasite control was provided by administering Expar
(external) and Panacur^ (internal) according to label instructions. During processing, ears were palpated for,
evidence of viable implants. None were found. During the receiving period long hay and the step 1 diet
(Table 1) were fed. The milled feed delivery was limited to 1.5% BW during receiving (3 or 4 d).
Initial and final individual BW each were recorded on two consecutive days. Initial implants were
administered during the second initial BW processing. Re-implanting with revalor-s was done during the
d-56 BW processing. Implant integrity was evaluated at the next weigh day following implanting. Interim
BW were determined as noted in Table 2. All BW were collected with no prior restriction of feed or water.
Cattle were fed twice daily. A five step program was used to adapt cattle to the finishing diet (Table 1).
Feed calls were made daily at 0700 based on bunk and cattle condition. A clean bunk management system
was used. Rations were mixed using a stationary mixer. A single batch of feed was distributed within
replicate so that implant treatment and feed batch were not confounded. Samples of feed ingredients were
collected once each week. The analyses of these samples were combined with batching records to
reconstruct the composition of diets fed. While on step 5, these diets contained DM 75.5% ± .5, CP
12.4% ± .07, ADF 5.6% ± .15, NDF 12.6% ± .8, and ash 2.7% ± .04. The estimated final diet energy
density was 94.8 Mcal/cwt ± .12 and NEg 63.7 Mcal/cwt ± .10. All pens were fed the final diet (5)
within 15 d on trial. These weekly assays and feed delivery records were used to produce DMI summaries
each week or more frequently when necessary.
Initial and interim BW reported in Table 3 were not corrected for fill. The final BW referred to in Table 3
included a 3% shrink. This shrunk BW was used to calculate cumulative ADG and dressing percentage. To
evaluate the performance response to the re-implant treatment (4), performance variables were summarized
for the periods prior to (EARLY) and following re-implanting (LATE). The Group I cattle were fed for 131 d
and the Group II were fed for 145 d. This caused the LATE performance windows to be 57 to 131 and 57
to 145 d, for Group I and II, respectively.
Two steers were removed from the study, one for lameness and one suffered apparent metabolic disorders.
These individuals had been individually hospitalized prior to deleting them from the study. Their BW
contribution to the pen mean was deleted from the onset of the experiment. Feed records were corrected
for the days the subjects were hospitalized. It was assumed that these individuals consumed pen average
DMI up to the point of hospitalization.
On the evening following the final BW, steers were transported 75 miles to the beef packing plant at
Luverne, MM. They stood overnight and were processed at 0700 the following day. Individual carcass
identity was maintained. Hot carcass weight was recorded the day of slaughter. Longissimus area, ribfat
thickness, marbling score, bone maturity, lean maturity, KPH (omitted in Group I), and masculinity were
collected 24 h after exsanguination. Data were collected by SDSU personnel trained in carcass evaluation.
One steer was mishandled during transit and was not slaughtered as part of this experiment. Consequently,
carcass data were available for 397 subjects.
All performance variables were evaluated in a statistical model that included treatment, group, and the
treatment x group interaction using the GLM package of SAS. The experimental unit in these analyses was
the pen. Orthogonal contrasts were used to separate treatments. The contrasts included (a) control vs
implants; (b) Synovex Plus and revalor-s vs Ralgro/revalor-s, and (c) Synovex Plus vs revalor-s. Carcass
data were handled similarly except that the individual steer was considered to be the experimental unit.
Results
The initial BW for Groups I and II were 782 lb ± 5.5 and 661 lb ± 4.2, respectively. The predominately
Angus x Hereford steers in Group I were large framed and had never been implanted prior to entering our
feedlot. The Continental cross steers used in this study were smaller framed than the Angus x Hereford
steers. Initial body condition was not quantified. Flesh was considered comparable between the groups and
typical for yearlings entering our feedlot.
Implants increased {P<.001) ADG and DMI and reduced feed/gain (P<.001). These responses were
evident during most interim measures of performance (Table 3). In the latter stages of feeding period,
interactions developed between cattle group and implant treatment for ADG and feed/gain. The
nonimplanted steers in Group II were growing more rapidly and more efficiently than Group I
contemporaries during 113 to 130 d on feed. These (Group II) steers started on feed at a lighter weight
and were not as close to finish at 130 d. In contrast, the Group II steers implanted with Synovex Plus had
lower ADG at 112 d (3.63 vs 3.09) and 130 d (3.47 vs 2.44) than Group I contemporaries. The DMI of
these steers also tended to be lower during these interim periods.
Short intervals between BW measurements can be misleading. To average responses overtime ADG from
90 to 130 d was calculated (Table 3). This approach showed that cattle were becoming less efficient as
they approached harvest BW. A response to implanting was still in effect as feed/gain was 15% lower in
steers initially receiving Synovex Plus or revalor-s than in nonimplanted steers. There was an additional
11 % improvement (P<.01) in feed/gain during this period in re-implanted steers.
To evaluate the merits of re-implanting, data were calculated for 1 to 56 (early) and 57 to final (late)
feeding periods. During the early phase, combination implants caused better ADG and feed/gain than Ralgro
implants (P<.001). Synovex Plus tended (P<.095) to cause higher ADG than revalor-s. During the late
phase, re-implanted steers grew faster (P<.012) and more efficiently (P<.006) than single implant steers.
Interactions existed because the magnitude of response to implants diiffered between groups. This may be
an artifact of this experiment or that cattle respond differently to these implants based upon their relative
size when implants are administered.
Implants increased hot carcass weight (HCW) by 65 lb. The carcasses produced by implanted steers were
of comparable weight (Table 5). The dressing percentage was affected when comparing Synovex Plus and
revalor-s. This may have been due to differences in DMI at the termination of the feedlot study. _
Longissimus area was increased (P<.001) by implants. There was no appreciable influence on ribfat
thickness. Bone maturity and masculinity were increased by implants. Bone and lean maturity were greater
for re-implanted than single implanted cattle, but the magnitude of difference is probably inconsequential as
regards carcass value.
Influences on marbling were more distinctive. Implants reduced marbling scores and percentage Choice
carcasses (Table 5). Marbling scores were lower (P<.05) for single implant strategies (Synovex Plus and
revalor-s) than the re-implant strategy. These influences were more pronounced in the leaner cattle of
Group II (Table 6). As vyas noted earlier regarding late gain responses, cattle may be responding differently
to implants based on their relative size when implants are administered.
A desirable approach to addressing implant payout would be to evaluate changes in interim period
feed/gain. However, fluctuations in feed/gain within treatment can occur during latter stages of the feeding
period. This problem becomes exaggerated with short intervals of BW change. Because of these
circumstances, the interim ADG, DMI, and feed/gain were not useful for explaining differences in marbling
scores attributable to implant treatment. When intake was re-evaluated as DMI, g/kg BW the only
distinctive separation that occurred was much lower relative DMI for non-implanted steers. This response
began to appear after 112 d on feed (Figure 1).
To further evaluate implant payout, the energy density of live weight gain (EDq) was calculated as NEg
(McaD/liye weight gain (lb). Higher EDq values would be indicative of higher fat content in live weight gain.
The NEf^ and NEg intakes used were based upon tabular values for feedstuffs and actual feed ingredient
intakes. Maintenance requirements were calculated based upon the mean BW for each pen during interim
periods. The NE^ requirement was estimated to be increased by 10% during exposure to E2TBA implants
(Birkelo, personal communication). The final period was averaged to 138 d on feed.
During the initial 56 d EDq was lower (P<.05) in steers exposed to E2TBA. Ralgro caused only a slight
numerical decline from control values during this period. The EDq content of re-implanted steers converged
with the d-1 E2TBA treatments during the 57 to 89- and 90 to 112-d periods. The EDq of nonimplanted
steers continued to climb and create an increasingly wider separation from values for implanted steers.
During the final feeding period, the EDq was lower (P<.05) for re-implanted steers than for either d-1
E2TBA treatment. This followed a 137-d payout for the d-1 E2TBA treatments. The E2TBA implant payout
for the re-implant treatment was only 81 d at this point. The difference in EDq reflects more active implant
activity at this late date and is consistent with expectations of implant responses over time.
If the deposition of fat as marbling is most pronounced late in the feeding period, the EDq curves suggest
that marbling would be highest in the nonimplanted steers and lowest in the re-implanted steers.
Consistent with this concept, marbling scores were highest (P<.001) for the nonimplanted steers.
However, marbling scores were higher (P<.05) for the re-implanted steers than for those on the d-1 E2TBA
treatments. When the pattern of EDq is compared with the ranking by marbling scores, it is the early EDq
values that best matched the rank of marbling scores. The ED q was higher through 56 d for those
treatments causing higher marbling scores. The separation that occurred between the nonimplant and
re-implant treatments at d 89 may be indicative of the phase of growth when marbling scores among
re-implanted steers was depressed.
Conclusions
Actual payout optimums for implants were not defined by this research. In Group I it appeared that
Synovex Plus was more potent at 130 d than was revalor-s. This observation was reversed in the Group II
replication.
Cumulative feedlot production costs would be comparable for the implants used in that weight gain and
DMI were similar among implanted steers. There is an additional cost associated with re-implanting
(treatment 4). This cost may be offset by the increased carcass value associated with this strategy in the
Group II steers in some fed cattle pricing mechanisms. The explanation for improved grading associated
with re-implanting may relate to fewer total days of TBA exposure. However, an evaluation of gain energy
density suggested that it may be the influence of implants early in the feeding period that has the greatest
effect on marbling scores. Theoretically this influence may be lessened in cattle, carrying more flesh when
placed in the feedlot. This (along with genetics) would help explain why the Choice percentage can vary
dramatically among cattle receiving the same implant strategy. Consideration of this aspect of growth
would be important in determining optimum management of implants. Future studies may reveal that
Choice percentage may be dictated more so by the existing body condition when E2TBA implants are
administered than by the days from implanting to harvest.
Table 1. Diets fed (
Step 1 jj Step 2 Step 3 Step 4
i
Step 5 1 Step 5^ 1
% DM basis |
Corn silage | 55.00 135.00 25.00 15.00 10.00 1 1
Oat silage | 1 -
-
- 18.00 1
Whole shelled corn j 26.65 1 40.65 47.65 54.65 57.65 1 59.65 1
High moisture corn 1 9.75 115.75 18.00 121.00 23.00 1 23.00
LS460b 13.50 1
I
3.50 4.25 1 4.25 4.25 1
1
4.25 1
I
Soybean meal, 44%^ j 5.00 J5.00 5.00 5.00 5.00 1 5.00 1
Limestone^ |
I
.10 1.10 .10 .10 .10 1
i
\
.10
^Switch occurred on August 20, 1996. j
•^70% DM, contained 460 g monensin/T ARB. Diet provided 28.5 g monensin/T DMB. |
1
^Fed as a pelleted supplement that included tylosin. Diet provided 11 g tylosin/T DMB. (
Table 2. Processing schedule |
Group 1 jj 1 Group II
DOF Date ij J DOF 1 Date 1 j Procedure
-2 April 29 1 -2 1 May 21 | Allotment weight |
-1 April 30 1 -1 1 May 22 | Sort to pens
0 May 1 1 0 1 May 23 | Initial BW^
1 May 2 j
>w.w.v .V...W. w
1 1 1 May 24 J Initial BW2, implant
28 May 30 j 28 I June 21 BW, palpate implant j
\
56 June 27 |
I
1 56 1 July 19 1 BW, Re-implant (4) |
89
I
July 30
• , j
i 89 1 August 21 1j BW, palpate implant |
112 August 22 |
1
t
i
112 1 September 13 1 BW
130 September 9 | 1 130 1 October 1 j
j
1
1
BW 1
131 September 10 |
\
1 J BW 1
1
I 144 October 15 BW 1
11 1 145 October 16 j
1
BW 1
Table 3. Pooled performance summary
1 Treatment Contrast P < |
1
1
1
1
Control i
Synovex j
Plus
revalor- j
1
s ^
1
1
Ralgro |
revalor- |
s 1
SEM 1
1 vs
2,3,4 1
2,3 1
vs 4 i
i
2 vs 3 { Trt*Grp |
Initial BW, 1
lb j 721 721 722 1 722 1.7 NSa 1 NS 1 NS 1 NS 1
1 to 28 d 1
BW 28, lb 1 839 864 856 1 848 1
.....J
3.4 1 .001 .007 1 .120 I NS i
ADG, lb 1 4.23 5.10 4.81 1 4.49 1 .110 .001 1 .002 1 .073 1 NS 1
DMI, Ib/d 1 17.54 17.92 17.92 1 17.82 1 .257 1 NS NS 1 NS 1 NS
F/G 1 4.23 3.57 3.81 1 3.99 1 .095 .001 1 .015 1 .082 1 NS 1
29 to 56 d 1
1
BW 56, lb 1 953 1002 993 1 973 4.3 .001 .001 1 .129 1 NS 1\
ADG, lb 1 4.05 4.94 4.87 1 4.46 .114 1 .001 .004 1 NS j .005 1J
DMI, Ib/d 1 20.82 21.63 1 21.03 1 21.38 .287 1 .124 NS ! .148 1 NS 1
F/G 1 5.15 4.40 4.33 1 4.85 .091 .001 .001 1 NS 1 .001 1
57 to 89 d 1
1
BW 89, lb 1 1076 1146 1140 1 1122 1 4.8 .001 .001 1 NS 1 NS 1
ADG, lb 1 3.75 4.37 4.47 1
\
4.49 1 .106 .001 NS j NS 1 NS
1
DMI, Ib/d 1 22.27 1 23.40 23.32 i 23.12 .279 1 .004 NS 1 NS 1 NS 1
F/G 1 6.01 5.39 5.24 1 5.18 1 .129 1 .001 NS 1 NS 1 .149 1
90 to 112 1
d
- 1
BW 112, lb 1 1136 1 1223 1222 1 1207 6.3 1 .001 .055 1 NS 1 NS 1
ADG, lb 1 2.61 3.36 3.55 1 3.73 .159 .001 NS 1 NS 1 NS 1
DMI, Ib/d 1 21.52 23.85 23.68 1 23.88 .337 1 .001 NS 1 NS 1 NS 1
?
F/G 8.59 7.24 6.75 1 6.45 .361 1 .001 NS 1 NS 1 NS 1
113 to 130 d
BW 130, lb 1173 1277 1268 i 1267 6.0 .001 NS NS 1 .003 1
ADG, lb 2.03 2.96 2.54 3.29 .197 .001 .032 .146 I .003 1
DMI, Ib/d 20.14 23.87 23.35 23.63 .227 1 .001 1 1 .118 .001 1
F/G 11.14 8.85 9.89 7.49 .851 ; .021 1.082 1 NS .005
90 to 130 1
d
ADG, lb 2.36 3.18 3.10 3.54 .113 .001 .008 NS 1 .005 1
DMI, Ib/d 20.90 23.86 23.53 23.76 .248 .001 NS NS .025 1
F/G 9.02 7.67 7.63 i 6.79 .251 .001 .009 NS .001 1
Table 3. Continuf'd 1
1 Treatment j Contrast P < , |
1
Control j Synovex |Plus 1 revalor- |s Ralgro |revalor- |s 1 SEM 1 1 vs 12,3,4 1 2,3 !vs 4 1 2 vs i3 1 1Trt*Grp 1
Early (1 to 56 d) j
ADG, lb 4.14 1 5.02 1 4.84 4.48 1 .073
, ...J
.001 1 .001 .095 1
J
NS 1
DMI, Ib/d 19.18 1 19.77 1 19.47 19.60 1 .244 1 .135 1 NS NS 1j NS
F/G 1 4.65 1 3.95 1 4.05 4.40 J .044 1 .001 1 .001 NS 1 .029 1
Late (57 to end) I
ADG, lb 2.89 1 3.66 1 3.71 1 3.92 1 .073 | .001 .012 NS I .004 1
DMI, Ib/d 1 21.41 1\ 23.66 1 23.47 1 23.51 || .233 | .001 NS NS j .053 1
F/G 7.49 1 6.49 6.34 || 6.00 1 .114 1 .001 .006 NS 1 .001 1
Cumulative
Final BW^, lb 1191 1301 1298 1296
^
6.1
I
.001 NS NS
i
.007
3.92 3.88 3.86 .039 .001 NS NS .001 j
DMI, Ib/d 20.51
j
22.07 21.85 21.93 .200 .001 NS NS NS 1
F/G 6.56 5.63 5.63 5.69 .050 .001 NS NS .001 1
ap>.15. 1
•^Final BW includes a 3% shrink. |
Table 4. Interactions between implant and group 1
Treatment j Contrast P < |
Control i(1) j Synovex |Plus (2) 1 revalor- |s (3) 1 Ralgrorevalor- i
s (4) 1 SEM i
1 vs 1
2,3,4 1
I
I
2,3 1
vs 4 1
2vs 3jTrt*Grp |j
Late (56 to end)
ADG, lb 1
Group 1 j 2.63 J 3.81 1 3.65 1 3.85 ) .073 1 .001 1 .012 1 NS. .004 1
Group II 1 3.15 1
J
3.50 1 3.78 1 4.00
DMI, Ib/d 1
Group 1 j 21.23 1 24.26 1 23.80 1 23.30 .233 1 .001 1 NS 1 NS 1 .053 1
Group II i J 23.06^ 23.14 1I 23.72
F/G
Group 1
j
8.09 1 6.37 1 6.53 1
1
6.07 .114 i .001 1 .006 1
.?
NS j .001 1
Group II 6.88 1 6.60 1 6.14 1
J
5.94
Cumulative
ADG, lb
Group 1 2.93 3.95 J 3.75 1 3.68 .039 i .001 ! NS 1 NS 1 .001 1
Group II 3.35 J 3.89 1 4.01 4.04
DMI, Ib/d
Group 1
i
20.47 22.41 1 22.18 21.79 .200 1 .001 1 NS 1
j
NS . 1 NS 1
1
Group II 20.56 21.73 1 21.52
j
22.06
F/G
j
Group 1 6.98 1
1
5.68 1 5.91 5.92 .050 1 .001 1
I
NS 1 NS 1 .001 1
Group II 6.14 5.59 J 5.36 5.46
1 ^NS indicates P>.15. |
Table 5. Effect of Implant treatment on carcass traits |
i
\
i
1
Treatment Contrast P < |
I
1
i
1
j
1
Control ]
(1)
Synovex ]
Plus 1
(2)
revalor- 1
1
s ^
(3) 1
Ralgro
revalor-
s (4)
SEM
1 vs
2,3,4
2,3 1
vs 4 i
1
2vs 1
3 1
i
1
Trt*Grp j
1
HCW, lb 1
I
717 781 785 1^ 781 5.8 .001 NSf NS 1 .139 1
Dressing % 62.10 1 61.85 62.35 1 62.17 .161 NS NS .028 1 NS i1
REA, in2 1 12.77 1 13.86 13.82 1 13.64 .135 NS NS 1 NS 1
Ribfat, in. i .385 || .394 .419 1 .390 .014 1 NS NS NS 1 NS 1
1
1Marbling® jj 5.37 4.90 5.02 5.17 .082 .001 .026 NS 1 NS 1
1Bone 1 133
1maturity^ j| 145 146 149 1.7 .001 .114 NS 11J NS 1
1 Lean i 141 |
1maturity^ | 139 136 141 1.6 NS .054 NS 1 NS 1
1Masculinity*^ j -63 .96 1.03 1.05 .060 .001 NS NS 1 .002 1
1 % Choice® 68.4 1 43.0 i| 51.0 59.6
1 ®4.0 = select ; 5.0 = small . j
b,c-ioo = A; 200 = B. ]
1 "^scale 0 to 3; 3 = stag. 1
1 ®P = .002 by Chi square analysis. |
1 ^NS indicates P>.15. |
i 1
Table 6. Marbling scores and percentage choice by implant x group
Treatment
i
i
1
1
Item 1 Control (1) j
Synovex Plus 1
(2)
revalor-s j(3) j Ralgrorevalor-s (4) 0 i
'1
I
Marbllng^^ j Group 1 1 5.52 1 4.95 1 5.13 1 5.19 5.20 1
I
Group II 1
^ 1
5.21 j 4.85 1 4.90 1 5.16 5.03 j
Choice, 1
1
Group 1 j
j
67.4 1 54.0 1 58.0 1 59.2 59.6 1
\
t
Group II 1 69.4 1 32.0 1 44.0 1 60.0 1 51.3 1
1
Ribfat® 1 Group 1 1
1
.414 1 .430 .470 1 .418 j .433 1
1
Group II 1
.J
.356 1 .357 1 .369 1 .362 I .361 j
®Treatment effect (P<.001).
''Group effect (P< .05). |
1
^Treatment effect (P = .002). |
^Group effect (P=.09). J
®Group effect {P<.001). |
Figure 1. Feed intake per unit metabolic body size as affected by implants and days on feed.
Figure 2. Energy density of live weight gain as affected by implants and days on feed.
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Figure 1. Feed intake per unit metabolic body size as affected
by implants and days on feed.
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Figure 2. Energy density of live weight gain as affected
by Implants and days on feed
